Related Experiment Videos
Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms
M W McDermott1, M S Berger, Sandeep Kunwar
1Department of Neurosurgery, University of California, San Francisco, CA, USA. mcdermottm@neuro.ucsf.edu
Journal of Neuro-Oncology
|November 6, 2004
Summary
Focal radiation therapies like brachytherapy and radiosurgery show limited survival benefits for malignant gliomas. Improved targeting may enhance future treatment effectiveness for these brain tumors.
Area of Science:
- Neuro-oncology
- Radiation Oncology
Background:
- Malignant gliomas require effective local control strategies.
- Focal radiation therapies have evolved over time for glioma management.
Purpose of the Study:
- To review the literature on brachytherapy and radiosurgery for malignant gliomas.
- To evaluate the efficacy of these focal radiation techniques in newly diagnosed and recurrent cases.
Main Methods:
- Review of recent literature on brachytherapy and radiosurgery.
- Analysis of Phase 3 study results (pending publication) for radiosurgery.
- Consideration of findings from metabolic imaging studies.
Main Results:
- Brachytherapy did not demonstrate significant survival benefit in Phase 3 trials for glioblastoma.
- Early reports suggest negative outcomes for radiosurgery in a Phase 3 trial.
- These techniques are still used for recurrent gliomas.
Conclusions:
- Current focal radiation therapies have limitations in improving survival for malignant gliomas.
- Targeting challenges, possibly identified through metabolic imaging, may impact treatment efficacy.
- Further research into improved targeting is warranted.